May 2024
How women can reduce the risk of breast cancer by 50pc
The science is sound but is not widely known that many women at increased risk of breast cancer can halve the risk with “anti-hormone” drugs.
Fashion is a way to stand out. But sometimes camouflage is better
I was diagnosed with stage one hormone receptor-positive breast cancer in December. It’s the good kind, as these things go.
April 2024
OpenAI’s model all but matches doctors in assessing eye problems
Ophthalmology has been a big focus of efforts to put AI to clinical use and fix obstacles to take-up, such as the tendency of models to ‘hallucinate’ by creating fictitious data.
![“[Australia is] on the cusp of turning back the incidence of [breast] cancer, that has been going up and up,” Professor Kelly-Anne Phillips says.](https://static.ffx.io/images/$zoom_1.1779%2C$multiply_1%2C$ratio_1.777778%2C$width_1059%2C$x_0%2C$y_95/t_crop_custom/c_scale%2Cw_280%2Cq_52%2Cf_auto/8c09976f872186db14f4ea818d436316d6afce79)
How countries like Australia could prevent one in four breast cancers
While a global report has found up to a quarter of breast cancers in high-income countries can be prevented, Australia’s program is already under way.
Volpara Health takeover set to sail through shareholder vote
South Korean suitor Lunit moved to acquire the breast cancer detection medtech last year, entering into a scheme of arrangement with the board in December.
February 2024
How these company bosses handled their cancer diagnoses
These bosses know all too well what King Charles is going through, having been given their own confronting news.
December 2023
How do we eliminate the most diagnosed cancer in the world?
On Monday, Labor MP Peta Murphy became one of the nine women, on average, who lose their lives to breast cancer each day in Australia. Is a zero death target realistic?
August 2023
Winning strategy: Bringing AI to the task of medical imaging
Comment provided by the winner of the Research Commercialisation Award, the University of Sydney.
Icon Group cancer care provider expands to UK
Australia’s largest integrated provider of cancer care services has penned a new deal with Nuffield Health, the UK’s largest healthcare charity.
August 2022
Free saliva test for the young could prevent fatal cancers later
Researchers from Monash University are recruiting 10,000 people aged 18 to 40 to assess the public appetite for preventative genetic testing.
July 2022
Why 6000 extra prostate cancers is not really an increase at all
While official figures make it seem like an extra 6000 men will be diagnosed with prostate cancer this year, it is not the case.
State funeral slated for Victorian MP Jane Garrett
The MP’s family has accepted a state funeral to farewell the former emergency services minister who died from breast cancer at the age of 49.
March 2022
McGrath Foundation gains $40m to expand nursing program
The high-profile foundation will be given $39.8 million over three years as part of a $330.6 million package to improve the health of women and girls.
November 2021
Icon founders score $115m payday as EQT snaps up cancer care business
After several sales over the years, Cathie Reid and Stuart Giles make their final departure having made an estimated $350 million along the way.
October 2021
Researchers turn microscope slides into sensors to help detect cancer
Australian experts have transformed the regular glass slides used in microscopes,using them to detect very early signs of breast cancer in tissue samples.
Icon Group to invest $50m in South Australia cancer care
The final bidding is heating up for the cancer care services provider with four parties still in the process after its investment bankers received eight indicative offers.
July 2021
GenesisCare launches new early-stage breast cancer test in Australia
The KKR-backed group is also likely to receive further investment from shareholders as it aims for new partnerships and launches a global research strategy.
June 2021
Brandon Capital, Uniseed back cancer biotech start-up in $10m funding
Currus Biologics has been spun out of research conducted at the Peter MacCallum Cancer Centre for the first time.
April 2021
How Tesla inspired this pharma executive to change
Husband and wife, Carlo Montagner and Bozena Zembrzuski, founded Specialised Therapeutics Australia over a decade ago. Their future plans may include an IPO.
March 2021
Latitude offers payment plans for $5000 breast cancer test
The consumer finance business and pharmaceutical group Specialised Therapeutics Australia will offer a genomic breast cancer test on an interest-free plan over two years.